|
|
REVIEW ARTICLE |
|
Year : 2021 | Volume
: 2
| Issue : 1 | Page : 4-8 |
|
Needle stick injuries and postexposure prophylaxis for hepatitis B infection
Tarika Sharma1, Ashok Chaudhary2, Jitender Singh3
1 College of Nursing, Institute of Liver and Biliary Sciences, New Delhi, India 2 Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India 3 Department of Interventional Radiology, Shanti Mukand Hospital, New Delhi, India
Date of Submission | 28-Nov-2020 |
Date of Decision | 05-Dec-2020 |
Date of Acceptance | 12-Dec-2020 |
Date of Web Publication | 23-Mar-2021 |
Correspondence Address: Ms. Tarika Sharma College of Nursing, Institute of Liver and Biliary Sciences, New Delhi India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jascp.jascp_10_20
Hepatitis B virus (HBV) infection is a global public health challenge as roughly a quarter of the world's population has serological evidence of past or present hepatitis B virus (HBV) infection. Healthcare personnel, who work in healthcare settings, represent a high-risk population for serious, potentially life-threatening Hepatitis B Virus infections. Needle stick injuries pose a serious risk for occupational transmission of hepatitis B virus and may occur during various procedures such as needle recapping, operative procedures, blood collection, intravenous line administration, blood sugar monitoring, and due to improper sharps/needle disposal. Infections acquired through occupational exposure are largely preventable through strict control measures such as the use of safe devices, proper waste disposal, immunization and prompt management of exposures including the use of Post Exposure Prophylaxis. The current review highlights the first aid management, reporting, baseline investigations as well as post exposure prophylaxis for Hepatitis B following needle stick injury.
Keywords: Blood borne infections, first aid management, hepatitis B, needle stick injuries, postexposure prophylaxis, prevention, vaccine nonresponder, vaccine responder
How to cite this article: Sharma T, Chaudhary A, Singh J. Needle stick injuries and postexposure prophylaxis for hepatitis B infection. J Appl Sci Clin Pract 2021;2:4-8 |
How to cite this URL: Sharma T, Chaudhary A, Singh J. Needle stick injuries and postexposure prophylaxis for hepatitis B infection. J Appl Sci Clin Pract [serial online] 2021 [cited 2023 Mar 29];2:4-8. Available from: http://www.jascp.org/text.asp?2021/2/1/4/311759 |
Introduction | |  |
Hepatitis B is a dreadful infectious disease and a major global health problem.[1] Accidental exposure to blood and body fluid presents a serious public health concern, especially among healthcare workers (HCW) and constitutes a risk of transmission of blood borne viruses such as Hepatitis B virus, Hepatitis C virus and HIV.[2] Roughly a quarter of the world's population has serological evidence of past or present hepatitis B virus (HBV) infection. A total of 250 million people are estimated to have chronic hepatitis B (CHB) infection.[3] Viral hepatitis continues to be a major public health problem in India as well.[4] About 15-30 per cent cases of acute hepatitis in India is due to Hepatitis B Virus. HBV is contagious and can easily be transmitted from one infected individual to another by blood contact, from mother to child or by unprotected sexual intercourse. The main transmission routes include prenatal infection, skin and mucous membrane infections caused by contaminated blood or body fluid, sexual contact, and injection drug abuse. In addition, tattooing, ear piercing, acupuncture, dialysis, and even use of a syringe can be the source of infection.[5]
Healthcare personnel, including support staff, who work in healthcare settings, represent a high-risk population for serious, potentially life-threatening Hepatitis B Virus infections. Direct contact with blood and other body fluids is the most common or frequent risk healthcare workers encounter while caring for patients.[6] Studies in the United States have shown that the risk of acquiring HBV after being stuck with a needle from an HBV+ client ranged from 27 to 37%.[7]
Needle stick injuries (NSIs) are one of the most important occupational hazards among healthcare workers (HCWs) globally. According to WHO, more than two million occupational exposures to sharp injuries occur among around 35 million HCWs annually.[8] Results of a systematic review and meta analysis inclusive of 87 studies performed on 50,916 HCWs in 31 countries worldwide to determine the global prevalence and causes of NSIs among HCWs shows that the one-year global pooled prevalence of NSIs among HCWs was 44.5% (95% CI: 35.7, 53.2).[9] Needle stick injuries pose a serious risk for occupational transmission of blood pathogens such as human immunodeficiency virus (HIV), hepatitis B virus and hepatitis C virus (HCV).[10] The risk of seroconversion following a NSI is highest for HBV (6%–30%) followed by HCV (0.5%–10%) and is lowest for HIV (0.3%).[11] Needle stick injury (NSI) is defined as percutaneous exposure where the skin is breached by a needle or any sharp object contaminated by blood or other bodily fluid due to accidental pricks.[12] NSI is the second most common cause of occupational injury within the National Health Services[13] and can occur during various procedures such as needle recapping, operative procedures, blood collection, intravenous line administration, checking blood sugar, and due to improper sharps/needle disposal.
The incidence of needle injury reported is about 100,000/year in the United Kingdom and about 600,000–1,000,000/year in the United States of America.[14] The reported authentic data of NSI in India are scarce due to infrequent reporting.[15] The main problem because of underreporting of NSIs is that the people who are exposed could not be given post exposure prophylaxis (PEP) at appropriate time to prevent the development of infection in the person who has experienced NSI.[16]
Infections acquired through occupational exposure are largely preventable through strict control measures such as the use of safe devices, proper waste disposal, immunization and prompt management of exposures including the use of Post Exposure Prophylaxis. This review presents the first aid management, reporting, baseline investigations as well as post exposure prophylaxis for Hepatitis B following needle stick injury.
First Aid Management after Occupational Exposure | |  |
First aid management depends on the type of exposure to blood and body fluids. Broadly the health care professionals may have two types of exposure; Percutaneous Exposure and Mucocutaneous exposure. Percutaneous Exposure is defined as an exposure event occurring when a needle or other sharp object penetrates the skin whereas mucocutaneous exposure refers to the contact of mucous membrane (e.g., eyes, nose, or mouth) with the body fluids or blood. Depending on these two, there may be four types of occupational exposures to blood and body fluids as described in [Table 1].
The first aid management for each type of exposure is different and is shown in the following [Figure 1]. | Figure 1: First aid management depending on type of exposure to blood and body fluids
Click here to view |
Reporting | |  |
Report the exposure to the department responsible for managing exposures (e.g., occupational health, infection control) is very important. Prompt reporting is essential because, in some cases, postexposure treatment may be recommended and it should be started as soon as possible. It is mandatory for all the hospitals to have a preset reporting protocol and all health care professionals must be aware of this protocol.
Baseline Investigations | |  |
The source patient must be tested for HbsAg as soon as possible after taking his consent. If the report is found to be positive (reactive for HbsAg), the exposed person must also be tested for HbsAg.
Postexposure Prophylaxis | |  |
The mainstay of postexposure prophylaxis (PEP) is hepatitis B vaccine, but, in certain circumstances, hepatitis B immune globulin is recommended in addition to vaccine for added protection. The decision to begin treatment is based on several factors, such as:
- Whether the source individual is positive for hepatitis B surface antigen
- Whether exposed person has been vaccinated
- Whether the vaccine provided immunity to the exposed person.
The exposed person can be classified into any of the following category
- Unvaccinated
- An individual who has not received Hepatitis B vaccine.
- Responder
- Individuals in whom anti HBs titre is ≥10mIU/ml after receipt of the Hepatitis vaccine series (anti HBs testing done 1-2 months after final dose of Hepatitis B vaccine) are considered as vaccine responders or immune to Hepatitis B vaccine.
- Nonresponder
- Hepatitis B vaccine “non-responder” refers to a person who does not develop protective surface antibodies after completing two full series of the hepatitis B vaccine
- Persons who do not respond to the primary hepatitis B vaccine series (i.e., anti-HBs <10 mIU/mL) should complete a second 3-dose vaccine series
- Revaccinated persons should be retested at the completion of the second vaccine series, 1-2 months following the last shot of the series[17]
- If anti HBs titre is <10 mIU/mL the person is considered as non responder.
- Unknown response
- An individual who has received the complete series of Hepatitis B vaccine but has not undergone anti HBs testing afterwards.
Postexposure prophylaxis for hepatitis B depends on the three scenarios given below
- Scenario 1: Source patient is found to be HbsAg Positive
- Scenario 2: Source patient is found to be HbsAg Negative
- Scenario 3: Source patient could not be tested or unknown.
Scenario 1: Source patient is found to be hepatitis B surface antigen positive
- Exposed person: Unvaccinated
- If the exposed person is unvaccinated or incompletely vaccinated and source patient is HBsAg-positive, the PEP has be started as early as possible preferably within 48 hours (but not later than 7 days after exposure). The exposed person should receive 1 dose of HBIG (0.06 ml/kg or 5.0 ml for adults) and 1 dose (1 ml = 20 ug) of Hepatitis B vaccine administered after the exposure. Hepatitis B vaccine may be administered simultaneously with HBIG at a separate anatomical injection site (e.g., separate limb). The HCP should complete the Hepatitis B vaccine series according to the vaccination schedule (0, 1 and 6 months)
- Exposed person: Previously vaccinated known responder
- Exposed person should be tested for anti HBs titre. If anti-HBs titre is adequate (≥10 mIU/mL), treatment is not required. If anti-HBs titre is inadequate (<10 mIU/mL), booster dose of Hb vaccination (2ml = 40 ug) must be administered
- Exposed person: Previously vaccinated known non responder
- The exposed person should receive 2 doses of HBIG. The first dose should be administered as soon as possible after the exposure, and the second dose should be administered 1 month later
Or
- The exposed person should receive 1 dose of HBIG and 1 dose of Hepatitis B vaccination as soon as possible after the exposure.
- Exposed person: Previously vaccinated, response unknown
- In this case, the exposed person must be tested for anti HBs titre, if titre value is adequate (≥10 mIU/mL), there is no need of any treatment. If titre value is inadequate (<10 mIU/mL), the exposed person must be administered 1 dose of HBIG and booster dose of Hepatitis B vaccination as soon as possible after the exposure.
Scenario 2: Source patient is found to be hepatitis B surface antigen negative
- If the source patient is HBsAg-negative, the unvaccinated exposed person should complete the Hepatitis B vaccine series according to the vaccination schedule.
Scenario 3: Source patient could not be tested or unknown hepatitis B surface antigen status
- Exposed person: Unvaccinated
- The exposed person should complete the Hepatitis B vaccine series according to the vaccination schedule.
- Exposed person: Previously vaccinated known responder
- In this case the treatment is not required as the exposed person is already vaccinated and a responder too.
- Exposed person: Previously vaccinated known nonresponder
- If known high risk source, may treat as if source is HbsAg positive and follow the following regimen
- The exposed person should receive 2 doses of HBIG. The first dose should be administered as soon as possible after the exposure, and the second dose should be administered 1 month later
Or - The exposed person should receive 1 dose of HBIG and 1 dose of Hepatitis B vaccination as soon as possible after the exposure.
- Exposed person: Previously vaccinated, response unknown
- The exposed person must be tested for anti HBs titre, if titre value is adequate (≥10 mIU/mL), there is no need of any treatment. If titre value is inadequate (<10 mIU/mL), the exposed person must be administered booster dose of Hepatitis B vaccination as soon as possible after the exposure.[18] A brief explanation of post exposure prophylaxis is also given in [Table 2].
Prevention of Needle Stick Injuries | |  |
Following points can be taken into consideration to prevent the Needle stick injuries and associated exposure to blood and body fluids among health care professionals:
- Avoid using needles whenever safe and effective alternatives are available
- Use needle devices with safety features
- Follow standard precautions for all patients
- Strictly adhere to the bio medical waste management protocol of the facility
- Avoid recapping or bending needles that might be contaminated. One hand scoop technique may be used as an alternative to recapping
- Take extra caution while handling needles or any other sharps
- Plan for the safe handling and disposal of needles before use
- All the healthcare professionals must be vaccinated against hepatitis b virus
- Report any needle stick and other sharps injury immediately as per the hospital protocol[19]
- Efforts should be taken to initiate effective surveillance as well as a reporting system that could contribute to reducing the occurrence of needle stick injuries at large.[20]
Conclusion | |  |
Needle stick injuries are the potential mode of exposure to and transmission of Hepatitis B infection among healthcare workers. These may occur in the emergency departments, in the operating room, in the wards, in the radiology or other departments and may be related to faulty needle insertion techniques, needle recapping, or incautious disposal of contaminated needles and sharps. Standard precautions, Preventive measures, Safe injection practices, Prompt first aid management, Appropriate reporting and Post exposure prophylaxis (if required) are the main strategies for dealing with this dreadful condition.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | Bhattarai S, Smriti KC, Pradhan PM, Lama S, Rijal S. Hepatitis B vaccination status and needle-stick and sharps-related Injuries among medical school students in Nepal: A cross-sectional study. BMC Res Notes 2014;7:774. |
2. | Ngwa CH, Ngoh EA, Cumber SN. Assessment of the knowledge, attitude and practice of health care workers in Fako division on post exposure prophylaxis to blood borne viruses: A hospital based cross-sectional study. Pan Afr Med J 2018;31:108. |
3. | Akyıldız M, Ahıskalı E, Zeybel M, Yurdaydın C. Regional epidemiology, burden, and management of hepatitis B virus in the Middle East. Clin Liver Dis (Hoboken) 2019;14:212-4. |
4. | Khuroo MS. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med 1980;68:818-24. |
5. | Mesfin YM, Kibret KT. Assessment of knowledge and practice towards hepatitis B among medical and health science students in Haramaya University, Ethiopia. PLoS One 2013;8:e79642. |
6. | Chouhan S. Hepatitis B prophylaxis practice among medical students: An overview. Hepatitis B Annu 2008;5:102. |
7. | Ababa A. Infection Prevention and Patient Safety: Reference Manual for Service Providers and Managers in Healthcare Facilities of Ethiopia. FMOH; 2010. |
8. | |
9. | Bouya S, Balouchi A, Rafiemanesh H, Amirshahi M, Dastres M, Moghadam MP, et al. Global prevalence and device related causes of needle stick injuries among health care workers: A systematic review and meta-analysis. Ann Glob Health 2020;86:35. |
10. | Jayanth ST, Kirupakaran H, Brahmadathan KN, Gnanaraj L, Kang G. Needle stick injuries in a tertiary care hospital. Indian J Med Microbiol 2009;27:44-7.  [ PUBMED] [Full text] |
11. | Hadaway L. Needlestick injuries, short peripheral catheters, and health care worker risks. J Infus Nurs 2012;35:164-78. |
12. | Bidira K, Woldie M, Nemera G. Prevalence and predictors of needle stick injury among nurses in public hospitals of Jimma Zone, South West Ethiopia. Int J Nurs Midwifery 2014;30:90-6. |
13. | Adams S, Stojkovic SG, Leveson SH. Needlestick injuries during surgical procedures: A multidisciplinary online study. Occup Med (Lond) 2010;60:139-44. |
14. | Ghauri AJ, Amissah-Arthur KN, Rashid A, Mushtaq B, Nessim M, Elsherbiny S. Sharps injuries in ophthalmic practice. Eye (Lond) 2011;25:443-8. |
15. | Muralidhar S, Singh PK, Jain RK, Malhotra M, Bala M. Needle stick injuries among health care workers in a tertiary care hospital of India. Indian J Med Res 2010;131:405-10.  [ PUBMED] [Full text] |
16. | Wilburn SQ. Needlestick and sharps injury prevention. Online J Issues Nurs 2004;9:5. |
17. | |
18. | Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, et al. Prevention of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2018;67:1-31. |
19. | Falagas ME, Karydis I, Kostogiannou I. Percutaneous exposure incidents of the health care personnel in a newly founded tertiary hospital: A prospective study. PLoS One 2007;2:e194. |
20. | Saadeh R, Khairallah K, Abozeid H, Al Rashdan L, Alfaqih M, Alkhatatbeh O. Needle Stick and sharp injuries among healthcare workers: A retrospective six-year study. Sultan Qaboos Univ Med J 2020;20:e54-62. |
[Figure 1]
[Table 1], [Table 2]
|